Eden isotope facility reaches mandatory NRC hearing

The Nuclear Regulatory Commission held a mandatory hearing September 29 on Eden Radioisotopes’ construction-permit application for the proposed Eden Isotope Production Complex near Eunice, New Mexico. The NRC hearing notice identifies the proceeding as part of the agency’s review of a new medical-isotope production facility.

Eden submitted its application on May 5, according to the NRC’s advanced-reactor application page. The agency subsequently posted the application and hearing materials. A mandatory hearing allows the commission to examine the record and the staff’s review before deciding whether required findings can be made.

The milestone does not authorize construction by itself. Nuclear projects advance through a sequence of safety, environmental and adjudicatory steps, and the commission’s decision must be reflected in an order or permit. The hearing is therefore evidence of review progress, not a substitute for the final licensing action.

For the project team and supply chain, licensing status affects when design assumptions can become committed procurement. Specialized buildings, confinement and ventilation systems, radiation monitoring, security, process equipment and quality assurance all have to align with the approved licensing basis. Changes during review can affect equipment specifications and construction sequencing.

The next indicators are the commission’s findings, any construction permit decision and the applicant’s subsequent implementation schedule. Market participants should rely on the NRC docket for authoritative status and should not infer that the September 29 hearing established a start date or guaranteed approval.

Representative nuclear-fuel photo: NRC staff tour the proposed TRISO-X site, February 2023. Photo by the U.S. Nuclear Regulatory Commission, CC BY 2.0. No editorial alterations; display versions may be resized or cropped.